Neogen Q4 FY26 net loss narrows to $11.3 million; revenue slips 0.1% to $225.3 million
NEOG•Q4 FY26 results
Neogen posted Q4 FY26 revenue of $225.3 million, down 0.1% year over year.
Net loss narrowed to $11.3 million, or $(0.05) per diluted share, from a much larger loss a year earlier.
Adjusted EBITDA (non-GAAP) rose to $45.4 million from $40.6 million; margin widened to 20.2% from 18%.
Segment performance and FY27 outlook
Food Safety revenue increased 3.1% to $166.8 million, while Animal Safety revenue fell 8.2% to $58.5 million.
Neogen guided FY27 revenue at $880-$885 million, with adjusted EBITDA (non-GAAP) of $180-$182 million; the Petrifilm transition is slated to start November 2026.
